Holding(s) in Company | 19-Nov-2024 | 09:49 | RNS |
Filing of 10Q form | 07-Nov-2024 | 07:00 | RNS |
Third Quarter 2024 Financial Results | 07-Nov-2024 | 07:00 | RNS |
Exercise of options and PDMR dealing | 06-Nov-2024 | 13:43 | RNS |
Total Voting Rights | 04-Nov-2024 | 13:23 | RNS |
Exercise of options and PDMR dealing | 31-Oct-2024 | 07:00 | RNS |
Grant of Options and Restricted Stock Units | 18-Oct-2024 | 09:24 | RNS |
MaxCyte Appoints Cynthia Collins to Board | 15-Oct-2024 | 13:05 | RNS |
Notice of Results | 11-Oct-2024 | 13:00 | RNS |
MaxCyte Appoints Ali Soleymannezhad as CCO | 10-Oct-2024 | 13:05 | RNS |
Exercise of options and PDMR dealing | 03-Oct-2024 | 09:41 | RNS |
Exercise of options and PDMR dealing | 01-Oct-2024 | 09:47 | RNS |
Total Voting Rights | 01-Oct-2024 | 07:00 | RNS |
Holding(s) in Company | 27-Sep-2024 | 16:15 | RNS |
Holding(s) in Company | 27-Sep-2024 | 15:29 | RNS |
Currency | UK Pounds |
Share Price | 266.00p |
Change Today | 4.00p |
% Change | 1.53 % |
52 Week High | 420.00p |
52 Week Low | 262.00p |
Volume | 47,020 |
Shares Issued | 105.43m |
Market Cap | £280.46m |
Beta | 0.36 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 4 |
Buy | 3 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 7 |
No dividends found |
Time | Volume / Share Price |
17:05 | 3,000 @ 266.00p |
17:05 | 484 @ 266.00p |
16:20 | 3,000 @ 269.20p |
16:19 | 484 @ 266.50p |
16:18 | 1,460 @ 263.00p |
You are here: research